Skip to content

   Pharma Publications

Neuropsychopharmacology
  • IN MEMORIAM: Floyd E. Bloom, M.D
    Published on 2025-03-04
    1 year ago
  • Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates
    Published on 2025-02-27
    1 year ago
  • A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
    Published on 2025-02-27
    1 year ago
  • The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
    Published on 2025-02-26
    1 year ago
  • Connectome-based predictive modeling of early and chronic psychosis symptoms
    Published on 2025-02-26
    1 year ago
  • The prelimbic prefrontal cortex mediates the development of lasting social avoidance as a consequence of social threat conditioning
    Published on 2025-02-26
    1 year ago
  • A projection from the medial prefrontal cortex to the lateral septum modulates coping behavior on the shock-probe test
    Published on 2025-02-26
    1 year ago
« Previous 1 … 52 53 54 55 56 … 143 Next »
Journal of Psychopharmacology
  • Wistar Kyoto rats exhibit decreased serotonin neuronal firing and increased norepinephrine burst activity but dampened hippocampal α2-adrenoceptor sensitivity
    Published on 2023-11-09
    3 years ago
  • Causes, clinical characteristics, and outcomes of high lithium levels and intoxications: Retrospective analysis of patient records
    Published on 2023-11-09
    3 years ago
  • Kynurenine pathway and suicidal ideation in treatment-resistant depression
    Published on 2023-11-09
    3 years ago
  • Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview
    Published on 2023-11-08
    3 years ago
  • The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review
    Published on 2023-11-08
    3 years ago
  • The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies
    Published on 2023-10-31
    3 years ago
  • Psychological and physiological effects of extended DMT
    Published on 2023-10-28
    3 years ago
« Previous 1 … 52 53 54 55 56 … 145 Next »
European Neuropsychopharmacology
  • The complex scenario behind the term antipsychotic drug
    Published on 2023-12-21
    2 years ago
  • Can antipsychotics prevent transition to psychosis in high-risk population?
    Published on 2023-12-15
    2 years ago
  • From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.
    Published on 2023-12-12
    2 years ago
  • Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices
    Published on 2023-12-08
    2 years ago
  • Investigation of TRPV1 gene expression in bipolar disorder and its association with CB1 and MOR gene expression
    Published on 2023-12-07
    2 years ago
  • The never-ending problem: Sample size matters
    Published on 2023-12-06
    2 years ago
  • Obsessive–compulsive symptoms and 15q11.2q13.1 duplication syndrome
    Published on 2023-12-02
    2 years ago
« Previous 1 … 52 53 54 55 56 … 166 Next »

   Pharma Pub